As revealed by Prof. Zhong Nanshan, expert in respiratory diseases and academician of Chinese Academy of Engineering the latest revision of the "diagnostic plan for epidemic atypical pneumonia (SARS)" has already been completed, which is to be published after the approval of the Ministry of Health. In the course of revision the effectiveness of the two methods for early diagnosis of SARS come to over 90 percent and they are able to find out through serum the antigenic infection within 5 -- 7 days after the oncoming of the SARS disease. Meanwhile in the study of the respiratory diseases in China a kind of anti-AIDS drug has been initially proved to be effective in the anti-virus treatment of the SARS patients.

On April 12, the newest report "Progress in the study of respiratory diseases" by the respiratory chapter of the Chinese Medical Association pointed out, 36 volunteers for the 1st phase clinic test of SARS vaccine are now underway for the study on the SARS antibody endurance while 24 volunteers are now respectively accepting the depleted SARS vaccine injection for them to produce neutralized antibody after six weeks. Up to the present moment they've all undergone 8 times of serum antibody monitoring without finding any obvious adverse effect.

At the same time the respiratory experts in China have made a complete sum-up on the methods used three times in the treatment of SARS diseases in 2003 and 2004 and they've come to an initial opinion that the kaletra drug used for anti-AIDS treatment is likely good for promoting the recovery of the peri-hemolymphocytes and reducing the mortality rate of SARS patients